982 / 1224
HCC TREATED RADICALLY
AUTHOR
DESIGN
CHILD-
PUGH /
BCLC
GRADE
NUMBER OF
PATIENTS
DOSE FRACTIONATION
SCHEME
2 y
LOCAL
CONTROL
2y
/MEDIAN
SURVIVAL
Andolino
(No transplant)
2010
Retrospective
A
B
/A-C
24
13
3x12-16Gy
5x8Gy
87%
47%/
20 Months
Kang
2012
Phase II
A
B7
/A-C
41
6
3x14-20Gy
95%
69%/
Not reported
Bujold
2013
Phase I-II
A
/A-C
102
6x4-9Gy
87% at 1 y
34%/
17 Months
Bibault
2013
Retrospective
A
B
/A-C
67
8
3x8-15Gy
90%
50%/
15 Months
Sanuki
2013
Retrospective
A
B
/A
158
27
5x8Gy
5x7Gy
93%
83%/
Not reported
Park
2013
Retrospective
A
B
/A-B
19
7
10x4-5Gy
88%
67%/
Not reported
Kimura
2015
Retrospective
A
B
/A-B
56
9
4x12Gy
(peripherally located
tumors)
100%
76%/
41 Months
Su
2016
Retrospective
A
B
/A-B
114
18
42-46Gy in 3-5 fractions
or
28-30Gy in 1 fraction
84%
82%/
Not reported